ADC Therapeutics SA (ADCT)vsRevolution Medicines Inc (RVMD)
ADCT
ADC Therapeutics SA
$1.03
-21.97%
HEALTHCARE · Cap: $432.45M
RVMD
Revolution Medicines Inc
$155.69
+4.02%
HEALTHCARE · Cap: $32.71B
Smart Verdict
WallStSmart Research — data-driven comparison
ADC Therapeutics SA generates 10570% more annual revenue ($79.17M vs $742,000). RVMD leads profitability with a 0.0% profit margin vs -173.0%. RVMD earns a higher WallStSmart Score of 24/100 (F).
ADCT
Avoid22
out of 100
Grade: F
RVMD
Avoid24
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Conservative balance sheet, low leverage
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -706.0% — below average capital efficiency
Revenue declined 9.5%
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : ADCT
The strongest argument for ADCT centers on Debt/Equity.
Bull Case : RVMD
The strongest argument for RVMD centers on Debt/Equity.
Bear Case : ADCT
The primary concerns for ADCT are EPS Growth, Market Cap, Return on Equity.
Bear Case : RVMD
The primary concerns for RVMD are EPS Growth, Profit Margin, Operating Margin.
Key Dynamics to Monitor
ADCT profiles as a turnaround stock while RVMD is a value play — different risk/reward profiles.
ADCT carries more volatility with a beta of 1.84 — expect wider price swings.
ADCT is growing revenue faster at -9.5% — sustainability is the question.
ADCT generates stronger free cash flow (-30M), providing more financial flexibility.
Bottom Line
RVMD scores higher overall (24/100 vs 22/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
ADC Therapeutics SA
HEALTHCARE · BIOTECHNOLOGY · USA
ADC Therapeutics SA, a biotechnology company focused on clinical stage oncology, develops Antibody Drug Conjugates (ADC) for patients suffering from hematologic malignancies and solid tumors. The company is headquartered in Epalinges, Switzerland.
Visit Website →Revolution Medicines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?